Exscientia inks €37m contract with GSKLatest NewsBritish pharma giant GlaxoSmithKline has secured access to Ex Scientia Ltd (Exscientia)s artificial intelligence (AI)-driven drug discovery platform. Read more 3 July 2017 https://european-biotechnology.com/wp-content/uploads/2024/04/Exscienta.jpg 849 1317 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2017-07-03 08:19:572017-07-03 08:19:57Exscientia inks €37m contract with GSK